H Shou-Huafeng
38 Guangji Road
Hangzhou, 310022, China
Hangzhou, 310022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Research progress in the diagnosis and treatment of pseudomyxoma peritonei.
Journal: World journal of surgical oncology
Published: November 24, 2025
The role of PAX1 and JAM3 methylation in predicting the pathological upgrading of cervical intraepithelial neoplasia before conization.
Journal: Scientific reports
Published: February 08, 2025
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for Pseudomyxoma peritonei originating from ovarian teratomas: A single-center case series and literature review.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: January 24, 2025
Primary Ovarian Lymphoma Treated With da Vinci Robotic-Assisted Laparoscopy: A Rare Malignant Tumor of the Ovary.
Journal: Journal of minimally invasive gynecology
Published: October 29, 2024
Zebrafish patient-derived xenograft system for predicting carboplatin resistance and metastasis of ovarian cancer.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: September 26, 2024
Cervical cancer screening: efficacy of PAX1 and JAM3 methylation assay in the triage of atypical squamous cell of undetermined significance (ASC-US).
Journal: BMC cancer
Published: July 29, 2024
Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 11, 2015
Association between metabolic syndrome and prognosis of endometrioid carcinoma
Journal: Zhonghua fu chan ke za zhi
Published: December 25, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026